Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.960
-0.020 (-0.67%)
Oct 27, 2026, 4:10 PM AEDT
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 547.74 million as of October 27, 2026. It is the 16,321st most valuable company in the world and the 314th biggest in Australia. Its market cap has increased by 2.80% in one year.
Market Cap
547.74M
Enterprise Value
859.71M
Revenue
736.15M
Global Rank
Country Rank
#314 Australia
PE Ratio
24.01
ChartMarket Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 547.74M, a decrease of -20.65%. That is a compound annual growth rate of -4.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 547.74M | 4.34% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.33B |
| Integral Diagnostics | 778.50M |
| Healius | 315.88M |
| Monash IVF Group | 278.59M |
| Identifai Genetics | 92.15M |
| Cryosite | 58.57M |
| BCAL Diagnostics | 27.65M |
| Microba Life Sciences | 25.91M |